1887
Volume 2015, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

ملخص

Congenital adrenal hyperplasia (CAH) is one of the most common inherited metabolic disorders. 21-hydroxylase deficiency is responsible for the majority of cases (90-95%) and considered the most common cause of genital ambiguity. There are no statistics concerning the prevalence of this disorder in Syria, although the high rate of consanguineous marriages indicates a possible high prevalence. This study aims to collect baseline information about CAH in Syria to evaluate the potential need of a screening program. All medical records of inpatients who had CAH as a final or presumptive diagnosis at the Children's Hospital of Damascus between 2008–2012, or were diagnosed elsewhere and then admitted at the hospital for the first time within the same period, were retrospectively reviewed and divided into two groups: confirmed and suspected cases. Eighty-nine cases were confirmed, 25 were still suspected. Of the 89 confirmed cases: 20 (22.5%) were males, 66 (74.1%) were females, and 3 were ambiguous. Sixty-one patients (68.5%) were of the salt wasting type and 28 (31.5%) were of the simple virilizing type. The mortality rate was 6.7%. Thirty-two females were assigned as males at birth. Seventeen cases (19.1%) underwent previous hospitalization. 69.7% of patients were not diagnosed during the first month of life. Of the 25 suspected cases: 12 were males, 8 were females and 5 were ambiguous. Confirmatory tests had not been performed because of death in 7 patients (28%) and early discharge upon parental request in another 7 patients (28%). A mandatory screening program for CAH in Syria seems necessary due to the obvious lack of awareness, delayed diagnosis and high expected prevalence. However, further efforts are needed to confirm the effectiveness of such a program in the Syrian society.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qmj.2015.11
٢٠١٥-٠٧-٣١
٢٠٢٤-١٠-٠٢
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2015/1/qmj.2015.11.html?itemId=/content/journals/10.5339/qmj.2015.11&mimeType=html&fmt=ahah

References

  1. Hayashi G, Faure C, Brondi MF, Vallejos C, Soares D, Oliveira É, Brito VN, Mendonca BB, Bachega TA. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia. Arq Bras Endocrinol Metabol. 2011; 55:8:632637.
    [Google الباحث العلمي]
  2. Dessinioti C, Katsambas A. Congenital adrenal hyperplasia. Dermatoendocrinol. 2009; 1:April:8791.
    [Google الباحث العلمي]
  3. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000; 21:3:245291.
    [Google الباحث العلمي]
  4. Haque S. Ambiguous genitalia. In: Salam MA, ed. Principles and practice of urology. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers 2013;:375380.
    [Google الباحث العلمي]
  5. Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 2001; 108::E68.
    [Google الباحث العلمي]
  6. Witchel SF, Azziz R. Congenital Adrenal Hyperplasia. North Am Soc Pediatr Adolesc Gynecol. 2011; 24:3:116126.
    [Google الباحث العلمي]
  7. Kandemir N, Yordam N. Congenital adrenal hyperplasia in Turkey: a review of 273 patients. Acta Paediatr. 1997; 86::2225.
    [Google الباحث العلمي]
  8. Mahdieh N, Rabbani B. 21-Hydroxylase Deficiency: Newborn Screening in Iran? Iran J Pediatr. 2012; 22:3:279280.
    [Google الباحث العلمي]
  9. Heather NL, Seneviratne SN, Webster D, Derraik JGB, Jefferies C, Carll J. Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994–2013. J Clin Endocrinol Metab. 2015; 100:3:10021008.
    [Google الباحث العلمي]
  10. Gidlöf S, Falhammar H, Thilén A, von Döbeln U, Ritzén M, Wedell A, Nordenström A. One hundred years of congenital adrenal hyperplasia in Sweden: A retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 2013; 1::3542.
    [Google الباحث العلمي]
  11. Al-Jurayyan NA, Al-Herbish AS, Abo Bakr AM, Al-Rabeeah AA, Al-Samarrai AI, Jawad AJ, Patel PJ, Abdullah MA. Congenital adrenal hyperplasia in a referral hospital in Saudi Arabia: Epidemiology, pattern and clinical presentation. Ann Saudi Med. 1995; 15:5:447450.
    [Google الباحث العلمي]
  12. Tayel SM, Ismael H, Kandil H, Abdrabuh AR, Sallam H. Congenital adrenal hyperplasia in Alexandria, Egypt: A high prevalence justifying the need for a community-based newborn screening program. J Trop Pediatr. 2011; 57:3:232234.
    [Google الباحث العلمي]
  13. Padidela R, Hindmarsh PC. Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010; 2010::656925.
    [Google الباحث العلمي]
  14. Kuribayashi I, Nomoto S, Massa G, Oostdijk W, Wit JM, Wolffenbuttel BHR, Shizuta Y, Honke K. Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele. Horm Res Paediatr. 2005; 63:6:284293.
    [Google الباحث العلمي]
  15. Somboonnithiphol K, Panamonta O, Kiatchoosakun P, Jirapradittha J. Newborn screening for congenital adrenal hyperplasia in Srinagarind Hospital, Khon Kaen University. Asian Biomed. 2011; 5:6:855859.
    [Google الباحث العلمي]
  16. Al Hosani H, Salah M, Osman HM, Farag HM, El-Assiouty L, Saade D, Hertecant J. Expanding the comprehensive national neonatal screening programme in the United arab emirates from 1995 to 2011. East Mediterr Heal J. 2014; 20:1:1723.
    [Google الباحث العلمي]
  17. World Population Prospects: The 2012 Revision [Internet]. United Nations. 2012 [cited 2015 May 1]. Available from: http://esa.un.org/unpd/wpp/unpp/panel_indicators.htm .
  18. Huynh T, Mcgown I, Cowley D, Nyunt O, Leong GM, Harris M, Cotterill AM. The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency. Clin Biochem Rev. 2009; 30::7586.
    [Google الباحث العلمي]
  19. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC, Endocrine Society . Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95::41334160.
    [Google الباحث العلمي]
  20. Wu JY, Sudeep , Cowley DM, Harris M, McGown IN, Cotterill AM. Is it time to commence newborn screening for congenital adrenal hyperplasia in Australia? Med J Aust. 2011; 195:5:260262.
    [Google الباحث العلمي]
  21. Othman H, Saadat M. Prevalence of consanguineous marriages in Syria. J Biosoc Sci. 2009; 41:5:685692.
    [Google الباحث العلمي]
  22. Lim YJ, Batch JA, Warne LG. Adrenal 21 -hydroxylase deficiency in childhood: 25 years' experience. J Paediatr Child Heal. 1995; 31::222227.
    [Google الباحث العلمي]
  23. Maiti A, Chatterjee S. Congenital adrenal hyperplasia: An Indian experience. J Paediatr Child Health. 2011; 47::883887.
    [Google الباحث العلمي]
  24. Azar MR, Nourbakhsh M, Nourbakhsh M. Congenital Adrenal Hyperplasia: Experience in Iranian Patients. J Compr Pediatr. 2012; 3:1:5461.
    [Google الباحث العلمي]
  25. Lubani MM, Issa ARA, Bushnaq R, AI-Saleh QA, Dudin KI, Reavey PC, el-Khalifa MY, Manandhar DS, Abdul Al YK, Ismail EA, et al., Prevalence of congenital adrenal hyperplasia in Kuwait. Eur J Pediatr. 1990; 149::391392.
    [Google الباحث العلمي]
/content/journals/10.5339/qmj.2015.11
Loading
/content/journals/10.5339/qmj.2015.11
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Research Article
الموضوعات الرئيسية 21-hydroxylase deficiencycongenital adrenal hyperplasiasalt wasting type and simple virilizing type

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error